Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors

NCT02472977 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
61
Enrollment
INDUSTRY
Sponsor class

Stopped Trial terminated because of lack of efficacy in the short term acute phase

Conditions

Interventions

Sponsor

Bristol-Myers Squibb